Evaluation of outcomes and cost-effectiveness of implementing next generation human papillomavirus (HPV) vaccination and associated primary HPV-based cervical cancer screening strategies in Australia [ 2014 - 2016 ]

Research Grant

Researchers: Prof Karen Canfell (Principal investigator) ,  A/Pr Sarah Lord ,  Dr Carolyn Nickson ,  Dr Mark Schiffman ,  Dr Philip Castle

Brief description This project involves using simulation modelling to predict the effect of the next generation human papillomavirus (HPV) vaccine, which will protect against infection with more strains of HPV. The investigators will use large datasets garnered from around the world to inform the assessment of the cost-effectiveness of this new vaccine in Australia and other key countries, and also to assess whether cervical screening will need to change in the future to account for the introduction of the new vaccine.

Funding Amount $AUD 697,071.18

Funding Scheme Project Grants

Notes Standard Project Grant